Galectin Therapeutics Inc (NASDAQ:GALT)

3.69
Delayed Data
As of 3:59pm ET
 +0.12 / +3.36%
Today’s Change
3.00
Today|||52-Week Range
18.62
+6.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization3.0K2.0K3.0K3.0K
 
 
 
 
 
 
Operating ExpensesGross Income-3.0K-2.0K-3.0K-3.0K
 
 
 
 
 
General Expenses2.8M4.8M3.4M3.5M
 
 
 
 
 
Research And Development1.4M2.8M1.6M2.0M
 
 
 
 
 
Total Operating Expenses2.8M4.8M3.4M3.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.8M-4.8M-3.4M-3.5M
 
 
 
 
 
Pre-Tax Equity Earnings---270.0K-67.0K-53.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-5.1M-3.4M-3.5M
 
 
 
 
 
Preferred Dividend-254.0K-240.0K-302.0K-278.0K
 
 
 
 
 
Net Income-2.9M-5.2M-3.4M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.7M20.3M22.0M22.1M
 
 
 
 
 
Shares To Calculate EPS Diluted20.7M20.3M22.0M22.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.27-$0.17-$0.17
 
 
 
 
 
EPS Diluted-$0.15-$0.27-$0.17-$0.17
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account